Skip to content
Governance Register

← US public companies

Schuler Jack W

SEC-identified person · CIK 1021412 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Vermillion, INC. vrml Officer filed 2013–2026
Biodesix INC BDSX Director filed 2020–2026
Accelerate Diagnostics, Inc AXK Director filed 2012–2024
Yield10 Bioscience, INC. YTEN Officer filed 2012–2024
Soleno Therapeutics INC SLNO Officer filed 2018–2023
Quidel Corp /DE/ QDEL Director filed 2006–2020
Biolase, INC BLTI Officer filed 2014–2020
Stericycle INC SRCL Director · Chairman filed 2006–2018
Neos Therapeutics, Inc. NEOS Officer filed 2015–2017
Hansen Medical INC HNSN Director filed 2013–2015
Oncternal Therapeutics, Inc. ONCT Director filed 2011–2014
Medtronic INC mdt Director filed 2006–2013
Transition Therapeutics Inc. TTHI Officer filed 2011–2011
Ventana Medical Systems INC vmsi Director filed 2006–2008
Icos Corp ICOS Director filed 2006–2007

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.